Alveolar eosinophilia in current smokers with chronic obstructive pulmonary disease in the SPIROMICS cohort.

[1]  R. Clark Resident memory T cells in human health and disease , 2015, Science Translational Medicine.

[2]  J. Curtis,et al.  Design of a multi-center immunophenotyping analysis of peripheral blood, sputum and bronchoalveolar lavage fluid in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS) , 2015, Journal of Translational Medicine.

[3]  S. Suissa,et al.  Inhaled corticosteroids in COPD: the clinical evidence , 2014, European Respiratory Journal.

[4]  Lisa M LaVange,et al.  Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS) , 2013, Thorax.

[5]  L. Wood,et al.  Multidimensional assessment and tailored interventions for COPD: respiratory utopia or common sense? , 2013, Thorax.

[6]  Christopher E Brightling,et al.  Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. , 2011, American journal of respiratory and critical care medicine.

[7]  R. Wood‐Baker,et al.  Assessment of airway inflammation using sputum, BAL, and endobronchial biopsies in current and ex-smokers with established COPD , 2010, International journal of chronic obstructive pulmonary disease.

[8]  I. Pavord,et al.  Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial , 2007, European Respiratory Journal.

[9]  J. Stoller Acute Exacerbations of Chronic Obstructive Pulmonary Disease , 2002 .

[10]  G. Koëter,et al.  Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD. , 2000, The European respiratory journal.